Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category.

International Journal of Cancer. Journal International Du Cancer
Sylvia H J JochemsTanja Stocks

Abstract

Obesity is a risk factor for advanced, but not localised, prostate cancer (PCa), and for poor prognosis. However, the detection of localised PCa through asymptomatic screening might influence these associations. We investigated height and body mass index (BMI) among 431 902 men in five Swedish cohorts in relation to PCa risk, according to cancer risk category and detection mode, and PCa-specific mortality using Cox regression. Statistical tests were two-sided. Height was positively associated with localised intermediate-risk PCa (HR per 5 cm, 1.03, 95% CI 1.01-1.05), while overweight and obesity were negatively associated with localised low- and intermediate-risk PCa (HRs per 5 kg/m2 , 0.86, 95% CI 0.81-0.90, and 0.92, 95% CI 0.88-0.97). However, these associations were partially driven by PCa's detected by asymptomatic screening and, for height, also by symptoms unrelated to PCa. The HR of localised PCa's, per 5 kg/m2 , was 0.88, 95% CI 0.83 to 0.92 for screen-detected PCa's and 0.96, 95% CI 0.90 to 1.01 for PCa's detected through lower urinary tract symptoms. BMI was positively associated with PCa-specific mortality in the full population and in case-only analysis of each PCa risk category (HRs per 5 kg/m2 , 1.11-1.22, P for ...Continue Reading

References

Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Jan 18, 2006·Cancer Causes & Control : CCC·Stephen J FreedlandElizabeth A Platz
Sep 4, 2008·Acta Oncologica·Lotti BarlowMats Talbäck
Feb 18, 2009·Statistics in Medicine·UNKNOWN Fibrinogen Studies Collaboration
Jan 19, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lauren P WallnerAruna V Sarma
May 9, 2012·International Journal of Epidemiology·Mieke Van HemelrijckUNKNOWN NPCR and PCBaSe Sweden
Dec 12, 2012·European Urology·Emma H AllottStephen J Freedland
Nov 26, 2013·Epidemiology·Martin LajousMiguel A Hernán
Apr 29, 2014·The Journal of Urology·Heather J ChalfinMisop Han
Dec 4, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Katarina TomicPär Stattin
May 2, 2015·The Prostate·Anna CantaruttiKatarina Bälter
Sep 12, 2015·International Journal of Cancer. Journal International Du Cancer·Elisabeth MöllerEdward Giovannucci
Mar 10, 2016·BMJ : British Medical Journal·Jessica TyrrellTimothy M Frayling
Jul 19, 2016·International Journal of Epidemiology·Chi GaoUNKNOWN the Colorectal Transdisciplinary Study (CORECT); Discovery, Biology and Risk of Inherited Variants in Breast Cancer (DRIVE);
Mar 2, 2017·BMJ : British Medical Journal·Maria KyrgiouKonstantinos K Tsilidis
Jun 27, 2017·Current Opinion in Urology·Mohammad AbufarajKarl-Dietrich Sievert
Oct 7, 2017·European Journal of Epidemiology·Hannah Louise BrookeRickard Ljung
Apr 27, 2018·International Journal of Cancer. Journal International Du Cancer·Xuexian FangJunxia Min
Jan 9, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M GenkingerS A Smith-Warner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.